Patents Assigned to Pinnacle Pharmaceuticals
  • Patent number: 7737132
    Abstract: The invention provides a new class of antibiotics to which pathogenic bacteria have not been exposed, and thus should not have developed resistance. This new class of antibiotics are derivatives of ?-cyclodextrin (?-CD), which is a cyclic molecule comprising seven D-glucose units.
    Type: Grant
    Filed: January 27, 2006
    Date of Patent: June 15, 2010
    Assignee: Pinnacle Pharmaceuticals
    Inventors: Noureddine Fahmi, Frank Werner Schmidtmann, Sidney Hecht